Cartel Labz Ibutamoren MK677 30mg 60 caps

Description

Cartel Labz Ibutamoren is a single-compound capsule product containing a declared 30 mg of MK-677 per capsule.

The manufacturer lists 60 servings per container, with one capsule defined as a serving. Each capsule contains 30 mg of MK-677, commonly known as Ibutamoren. Organic rice, rice flour, bovine gelatin and magnesium stearate are listed as additional ingredients.

What is Ibutamoren MK-677?

Ibutamoren, also identified as MK-677, MK-0677 or L-163,191, is an investigational, orally active, non-peptide growth-hormone secretagogue. It acts through the growth-hormone secretagogue receptor, also known as the ghrelin receptor or GHSR1a. MK-677 is not human growth hormone and is not a selective androgen receptor modulator.

Commercial descriptions frequently associate MK-677 with muscle development, recovery, sleep quality, appetite or changes in growth-hormone and IGF-1 levels. These statements should not be presented as guaranteed, medically approved or clinically established benefits of this commercial capsule product.

Product specifications

• Brand: Cartel Labz
• Product name: Ibutamoren MK-677
• Declared compound: MK-677
• Alternative names: Ibutamoren, MK-0677, L-163,191
• Declared amount: 30 mg per capsule
• Package size: 60 capsules
• Declared servings: 60
• Serving size shown on the manufacturer’s panel: 1 capsule
• Product form: capsules
• Compound category: investigational growth-hormone secretagogue
• Additional ingredients: organic rice, rice flour, bovine gelatin and magnesium stearate

The ingredient panel, capsule count, batch number, expiry date, storage information and warnings should always be checked against the physical container before the product is published or dispatched.

Product presentation and verification

Cartel Labz Ibutamoren MK-677 is supplied in a capsule container displaying the brand, compound designation and declared 30 mg specification.

A complete catalogue listing should allow customers to verify:

• the Cartel Labz branding,
• the Ibutamoren or MK-677 product name,
• the declared 30 mg specification,
• the 60-capsule package size,
• the complete ingredient panel,
• the batch and expiry information,
• the authenticity details,
• the condition of the original safety seal.

The physical label should remain the primary source for final product specifications. A container should not be distributed when its seal is damaged, the label appears altered or the physical specifications differ from the online description.

Safety and regulatory information

Ibutamoren is an investigational compound and should not be presented as an ordinary dietary supplement or approved medicine. FDA enforcement materials have classified products marketed with MK-677 for human performance-related purposes as unapproved new drugs in the United States.

Long-term safety has not been established. Reported concerns include fluid retention, changes in fasting blood glucose and insulin sensitivity, increased appetite, swelling, muscle or joint discomfort and potential cardiovascular or hormonal effects. FDA-related safety information has also identified a potential risk of congestive heart failure in certain patients.

The presence of a capsule format, serving information or a “Supplement Facts” panel does not establish that Ibutamoren is an authorised food ingredient or an approved medicinal product.

Information for tested athletes

Ibutamoren MK-677 is included on the World Anti-Doping Agency 2026 Prohibited List among growth-hormone secretagogues and their mimetics. Athletes and other individuals subject to anti-doping testing should treat the product as prohibited at all times.

This description is provided solely for accurate product identification and catalogue-reference purposes. It does not provide medical advice, dosage instructions, cycle guidance, stacking recommendations or guarantees of physical or performance-related results.